Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
TB Alliance
TB Alliance
Activities:
Research & Development
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Scleroderma treatment by Certa Therapeutics granted US FDA fast track
FT011 is a novel, first-in-class oral therapy for the treatment of chronic fibrosis in multiple organs
Naobios and Sumagen sign exclusive partnership to develop HIV vaccine
Naobios will manage process development and initiate launch of cGMP manufacturing for phase II clinical trials
Rapid increase in purchasing teams expected at CPHI North America
Macro-uncertainty and large CDMO acquisitions attributed to have driven a surge in R&D, purchasing and QC/QA attendees at event
Bio-Rad and Oncocyte partner to commercialise transplant monitoring with Droplet Digital PCR
The collaboration aims to provide researchers with tools to enable transformational monitoring of key biomarkers in solid tissue transplants
Upcoming event
Making Pharmaceuticals
23–24 April 2024 | Exhibition | Coventry, UK
See all
Related Content
Drug Delivery
World's first child-friendly TB medicines in correct doses
The new fixed-dose formulations for children will offer hope for the 400 children who needlessly die of TB each day
Research & Development
Novartis supplies tuberculosis drug candidates to TB Alliance
Included are drugs called indolcarboxamides that are active against drug sensitive and multi-resistant strains of TB
Research & Development
Sanofi and TB Alliance to accelerate TB drug development
Research collaboration will focus on optimising and developing compounds in the Sanofi library
Research & Development
South African trial milestone signals TB drug breakthrough
Combination of three drugs able to kill TB bacteria within two weeks
Research & Development
China to establish international r&d centre for global health
Partnership joins public and private sectors to develop new treatments for TB, malaria and HIV/AIDS
Research & Development
TB Alliance and AstraZeneca to fight tuberculosis
Agree to new research to speed up development of TB drugs
Subscribe now